Alector, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALEC research report →
About the company
Alector, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering new treatments for neurodegenerative disorders. A key program in its pipeline is AL001, a humanized recombinant monoclonal antibody currently undergoing Phase III clinical trials.
- CEO
- Arnon Rosenthal
- IPO
- 2019
- Employees
- 175
- HQ
- South San Francisco, CA, US
Price Chart
- Market Cap
- $228.71M
- P/E
- -1.82
- P/S
- 12.42
- P/B
- 21.94
- EV/EBITDA
- -1.60
- Div Yield
- 0.00%
- Gross Margin
- -61.24%
- Op Margin
- -741.33%
- Net Margin
- -680.83%
- ROE
- -295.17%
- ROIC
- -65.15%
- Revenue
- $21.05M · -79.07%
- Net Income
- $-142,929,000 · -20.06%
- EPS
- $-1.39 · -13.01%
- Op Income
- $-145,807,000
- FCF YoY
- 20.37%
- 52W High
- $3.40
- 52W Low
- $1.09
- 50D MA
- $2.05
- 200D MA
- $2.03
- Beta
- 0.59
- Avg Volume
- 702.09K
Get TickerSpark's AI analysis on ALEC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 17, 26 | Yaffe Kristine | other | 28,700 |
| Jun 17, 26 | Yaffe Kristine | other | 9,450 |
| Jun 17, 26 | SCHELLER RICHARD H | other | 28,700 |
| Jun 17, 26 | SCHELLER RICHARD H | other | 9,450 |
| Jun 17, 26 | Hammond Paula | other | 28,700 |
| Jun 17, 26 | Hammond Paula | other | 9,450 |
| Jun 17, 26 | GAROFALO ELIZABETH A. | other | 28,700 |
| Jun 17, 26 | GAROFALO ELIZABETH A. | other | 9,450 |
| Jun 17, 26 | Altmeyer Mark | other | 28,700 |
| Jun 17, 26 | Altmeyer Mark | other | 9,450 |
Our ALEC coverage
Recent articles, reports, and earnings notes.
No research on ALEC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALEC report →Similar companies
Peers in the same neighborhood.